Table 1 The use of orthobiologics
n (%) | |
|---|---|
Use (n = 265 respondents) | |
Never | 172 (64,9) |
Yearly | 44 (16,6) |
Monthly | 25 (9,4) |
Weekly | 18 (6,8) |
Daily | 6 (2,3) |
Type (n = 67 respondents) ab | |
Hyaluronic acid | 51 (76,1) |
Platelet-rich plasma | 18 (26,9) |
Autologous blood injection | 11 (16,4) |
Autologous conditioned serum | 7 (10,4) |
Bone matrix | 5 (7,5) |
Mesenchymal stem cells | 4 (6,0) |
Reason of use b | |
Effective treatment | 37 (55,2) |
Postponing surgical treatment | 30 (44,8) |
Placebo effect | 12 (17,9) |
Last resort | 5 (7,5) |
Research purposes | 3 (4,5) |
Satisfaction physician b | |
Very satisfied | 2 (3,0) |
Satisfied | 32 (47,7) |
Neutral | 29 (43,3) |
Unsatisfied | 1 (1,5) |
Very unsatisfied | 2 (3,0) |
Unanswered | 1 (1,5) |